MLchartDataset catalogue

liposomal amphotericin B

Term · Oncology and biomedicine · MLC-T-ONC-014812

A liposome-encapsulated formulation of the polyene antifungal antibiotic amphotericin B produced by the bacterium Streptomyces nodosus with antifungal activity. Amphotericin B binds to ergosterol, an essential component of the fungal cell membrane, and alters cell membrane integrity, resulting in leakage of intracellular components and cell rupture. This agent may also induce oxidative damage in fungal cells and has been reported to stimulate host immune cells. Compared to amphotericin B alone, liposomal delivery of amphotericin B allows for a greater drug concentration in target tissues while decreasing systemic side effects.

Table 1. Record
IdentifierMLC-T-ONC-014812
FieldOncology and biomedicine
AbbreviationL-AMB
Synonymsamphotericin B-lipid complex
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014812",
  "term": "liposomal amphotericin B",
  "field": "Oncology and biomedicine",
  "definition": "A liposome-encapsulated formulation of the polyene antifungal antibiotic amphotericin B produced by the bacterium Streptomyces nodosus with antifungal activity. Amphotericin B binds to ergosterol, an essential component of the fungal cell membrane, and alters cell membrane integrity, resulting in leakage of intracellular components and cell rupture. This agent may also induce oxidative damage in fungal cells and has been reported to stimulate host immune cells. Compared to amphotericin B alone, liposomal delivery of amphotericin B allows for a greater drug concentration in target tissues while decreasing systemic side effects.",
  "abbreviation": "L-AMB",
  "synonyms": [
    "amphotericin B-lipid complex"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/liposomal-amphotericin-b/"
}

Record 10,164 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.